Suma Hisayoshi, Tanabe Hiroaki, Uejima Tokuhisa, Suzuki Shinya, Horii Taiko, Isomura Tadashi
The Cardiovascular Institute, 7-3-10 Roppongi, Minato-Ku, Tokyo 106-0032, Japan.
Eur J Cardiothorac Surg. 2007 Dec;32(6):912-6. doi: 10.1016/j.ejcts.2007.09.021. Epub 2007 Oct 25.
To treat advanced heart failure due to idiopathic dilated cardiomyopathy, surgical ventricular restoration with mitral reconstruction was conducted and evaluated.
In 95 patients (81 men, mean age: 54 years), New York Heart Association class III/IV was 44/51, and 33 patients (36%) were inotropic dependent preoperatively. Mitral regurgitation (>or=2+) was noted in all patients. All patients underwent left ventriculoplasty (septal anterior ventricular exclusion in 38, partial left ventriculectomy in 57) and mitral reconstruction (repair 53, replacement 42). Fifty-two patients (55%) had concomitant tricuspid repair. Intra-aortic balloon pumping and left ventricular assist device was used in 24 patients and two patients, respectively.
Hospital mortality was 11.6% (11 of 95), with 6.6% (5 of 76) in elective and 31.6% (6 of 19) in emergency operations. The ejection fraction and cardiac index increased from 22.3+/-6.3% to 27.2+/-8.0% and from 2.3+/-0.5 ml/m2/min to 2.8+/-0.5 ml/m2/min, respectively (p<0.001). The endodiastolic volume index, endosystolic volume index and diastolic dimension decreased from 232.9+/-56.1 ml/m2 to 160.0+/-49.8 ml/m2, from 178.9+/-46.7 ml/m2 to 113.8+/-44.7 ml/m2 and from 82.0+/-9.0 mm to 68.9+/-11.6 mm, respectively (p<0.001). Late death occurred in 27 patients with 22 cardiac deaths. The mean NYHA class was 1.7 among the survivors. One-, 3- and 5-year survival rates were 72.8%, 61.4% and 50.5%, respectively. In the 62 patients who were non-inotropic dependent preoperatively, 1-, 3-, and 5-year survival rates (81.8%, 73.7% and 62.9%) were significantly better than the inotropic-dependent group (55.3%, 37.3% and 28.0%). Patients with mitral annuloplasty showed a significantly higher 5-year survival rate than patients with mitral valve replacement (59.6% vs 43.6%) in univariate analysis. By application of the exclusion site selection method, the two different ventriculoplasty procedures did not show significant difference in survival rates. Multivariate analysis showed that preoperative inotropes and old age were significant predictors for postoperative mortality.
The selected ventriculoplasty in combination with mitral annuloplasty is a useful option for patients with an extremely dilated left ventricle in idiopathic dilated cardiomyopathy. Surgery should be considered before inotropic dependency occurs when prior medical treatment has failed.
为治疗特发性扩张型心肌病所致的晚期心力衰竭,开展并评估了二尖瓣重建术联合手术性心室修复术。
95例患者(81例男性,平均年龄54岁),纽约心脏协会心功能分级III/IV级者分别为44/51例,33例患者(36%)术前依赖正性肌力药物。所有患者均存在二尖瓣反流(≥2+)。所有患者均接受了左心室成形术(38例行前间隔心室切除术,57例行部分左心室切除术)和二尖瓣重建术(53例行修复术,42例行置换术)。52例患者(55%)同时行三尖瓣修复术。分别有24例和2例患者使用了主动脉内球囊反搏和左心室辅助装置。
住院死亡率为11.6%(95例中的11例),择期手术死亡率为6.6%(76例中的5例),急诊手术死亡率为31.6%(19例中的6例)。射血分数和心脏指数分别从22.3±6.3%增至27.2±8.0%,从2.3±0.5 ml/m²/min增至2.8±0.5 ml/m²/min(p<0.001)。舒张末期容积指数、收缩末期容积指数和舒张期内径分别从232.9±56.1 ml/m²降至160.0±49.8 ml/m²,从178.9±46.7 ml/m²降至113.8±44.7 ml/m²,从82.0±9.0 mm降至68.9±11.6 mm(p<0.001)。27例患者发生晚期死亡,其中22例死于心脏疾病。幸存者的平均纽约心脏协会心功能分级为1.7级。1年、3年和5年生存率分别为72.8%、61.4%和50.5%。术前不依赖正性肌力药物的62例患者,其1年、3年和5年生存率(81.8%、73.7%和62.9%)显著高于依赖正性肌力药物组(55.3%、37.3%和28.0%)。单因素分析显示,二尖瓣环成形术患者的5年生存率显著高于二尖瓣置换术患者(59.6%对43.6%)。通过应用排除部位选择方法,两种不同的心室成形术在生存率方面未显示出显著差异。多因素分析显示,术前使用正性肌力药物和高龄是术后死亡率的显著预测因素。
对于特发性扩张型心肌病中左心室极度扩张的患者,所选的心室成形术联合二尖瓣环成形术是一种有效的治疗选择。当先前的药物治疗失败时,应在出现正性肌力药物依赖之前考虑手术治疗。